Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 4 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

VRTX News and Commentary

Caps

How do you think VRTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

745 Outperform
65 Underperform
 

All-Star Players

204 Outperform
13 Underperform
 

Wall Street

26 Outperform
1 Underperform
 

Top VRTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

GandDConnection (< 20)
Submitted April 05, 2015

We were deciding between this stock or New Oriental Education (EDU) -- a motley pairing if ever there was one! Vertex has been putting away $1B a year in R&D, which is a huge amount relative to sales, though just about 3%-4% of market cap. They have… More

MichaelHamilton (98.57)
Submitted June 25, 2014

$22bn,really??

VRTX VS S&P 500 (SPY)

Fools bullish on VRTX are also bullish on:

Fools bearish on VRTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VRTX.

Recs

0
Member Avatar ltdbjd (53.28) Submitted: 11/28/2017 10:56:00 PM : Outperform Start Price: $147.01 VRTX Score: +8.40

Vertex is primarily focused on cystic fibrosis medications. Currently their meds are used by an estimated 40% of CF patients. I believe this can dramatically increase, resulting in increased future revenues. Vertex has several medications/medication combinations in clinical trials, and so far things are looking positive.

Overall, I think Vertex has the potential to significantly increase in value.

Recs

0
Member Avatar TMFFishBiz (56.41) Submitted: 9/29/2017 9:02:24 AM : Outperform Start Price: $151.21 VRTX Score: -0.02

Excellent growth prospects, dominance in CF, and potential for expansion into other rare diseases.

Recs

0
Member Avatar TMFEBCapital (73.39) Submitted: 5/2/2017 12:11:09 PM : Outperform Start Price: $117.30 VRTX Score: +26.35

This biotech stock is seeing significant sales growth due to its cystic fibrosis drugs, and with new CF drugs expanding its total addressable patient population, I believe sales (and profit) are heading materially higher from here. If so, then taking advantage of a down day like today to pick up a little of it (in a diversified portfolio, of course) could pay off.

Leaderboard

Find the members with the highest scoring picks in VRTX.

Score Leader

bugeyebear

bugeyebear (< 20) Score: +912.02

The Score Leader is the player with the highest score across all their picks in VRTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
bugeyebear < 20 3/17/2008 Outperform 3Y $14.60 +1,036.30% +124.28% +912.02 0 Comment
Kudude 77.14 3/12/2008 Outperform 5Y $14.99 +1,006.74% +115.69% +891.05 0 Comment
lostontheprairie 67.39 3/12/2008 Outperform 5Y $14.99 +1,006.74% +115.69% +891.05 0 Comment
Salilp 76.86 3/17/2008 Outperform 5Y $15.07 +1,000.86% +126.19% +874.67 0 Comment
davidmouw2 < 20 3/14/2008 Outperform NS $15.43 +975.18% +115.62% +859.55 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. snazzysnazz 70.24 3/13/2008 Outperform 5Y $15.49 +971.01% +120.89% +850.12 0 Comment
NovaMechanika 25.73 3/20/2008 Outperform 3Y $15.55 +966.88% +119.06% +847.82 2 Comments
stnewbie 74.43 3/12/2008 Outperform NS $15.78 +951.33% +116.67% +834.66 0 Comment
PrincetonAl 93.75 3/7/2008 Outperform 3Y $15.86 +946.03% +120.86% +825.17 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.68 3/24/2008 Outperform 5Y $16.47 +907.29% +113.70% +793.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 85.56 10/13/2014 Outperform NS $107.35 +54.54% +44.24% +10.31 0 Comment
trackguggenheim < 20 10/3/2014 Outperform NS $105.37 +57.45% +40.39% +17.06 0 Comment
TrackGoldmanSach 77.84 9/5/2014 Outperform NS $94.68 +75.22% +37.24% +37.98 0 Comment
TrackCreditSuiss 90.98 7/15/2013 Outperform NS $87.14 +90.38% +63.55% +26.84 0 Comment
trackchardan 36.57 4/10/2013 Outperform NS $53.45 +210.38% +74.79% +135.60 0 Comment
TrackJanney 79.95 1/3/2013 Outperform NS $43.70 +279.63% +88.17% +191.46 0 Comment
TrackGoldmanSach 77.84 11/2/2012 Underperform NS $45.05 +81.02% +7.69% -73.33 4/19/2013 @ $81.55 0 Comment
TrackZacks < 20 9/26/2012 Underperform 3M $54.94 -18.49% -3.54% +14.95 11/12/2012 @ $44.78 1 Comment
TrackLazardCapit 83.30 8/7/2012 Outperform NS $52.30 -11.70% +4.53% -16.23 1/15/2013 @ $46.18 0 Comment
TrackJPMorgan 87.96 5/14/2012 Outperform NS $63.12 +162.83% +104.53% +58.30 0 Comment
TrackPoisedTo < 20 3/6/2012 Outperform 5Y $40.10 +313.72% +102.96% +210.75 0 Comment
TrackRBCCapMkts 87.13 12/19/2011 Outperform NS $33.26 +398.80% +127.03% +271.77 0 Comment
TrackZacks < 20 12/12/2011 Outperform 3M $29.35 +28.89% +6.65% +22.24 2/2/2012 @ $37.83 1 Comment
TrackBarclaysCap 91.02 12/9/2011 Outperform NS $29.48 +462.75% +118.16% +344.59 0 Comment
TrackJMP 83.26 10/4/2011 Outperform NS $42.03 +294.72% +151.96% +142.76 0 Comment
tracksummerstree 86.10 5/24/2011 Outperform NS $55.97 +196.41% +108.08% +88.33 0 Comment
TrackWedbush 87.61 2/24/2011 Outperform NS $43.62 +280.33% +110.80% +169.53 0 Comment
TrackGoldmanSach 77.84 2/9/2011 Outperform 5Y $38.40 +14.01% +7.86% +6.15 11/2/2012 @ $43.78 1 Comment
TrackBreanMurray 74.43 1/28/2011 Outperform NS $39.86 +34.24% +4.21% +30.03 5/4/2011 @ $53.51 0 Comment
TrackDawsonJames < 20 10/7/2010 Outperform NS $34.66 +378.65% +135.80% +242.85 0 Comment
TrackJimCramer 85.60 6/18/2010 Outperform 3W $36.82 +350.57% +145.87% +204.70 0 Comment
TrackMehtaPartne < 20 5/26/2010 Outperform NS $35.76 +363.93% +153.03% +210.90 0 Comment
TrackOppenheimer 68.75 3/4/2010 Outperform NS $41.82 +126.76% +74.50% +52.26 7/8/2014 @ $94.83 0 Comment
TrackWedbush 87.61 1/5/2010 Underperform NS $43.06 -12.41% -3.99% +8.42 5/26/2010 @ $37.72 0 Comment
TrackDeutscheSec 88.01 10/31/2009 Outperform NS $33.73 +391.85% +158.43% +233.42 0 Comment
TrackRBCCapMkts 87.13 10/10/2009 Outperform NS $33.14 +5.46% +18.02% -12.56 11/7/2011 @ $34.95 0 Comment
TrackZacks < 20 4/17/2009 Outperform 3M $28.03 +19.05% +22.21% -3.16 10/27/2009 @ $33.37 1 Comment
TrackJimCramer 85.60 4/6/2009 Underperform 3W $27.05 +36.12% +33.65% -2.47 6/19/2010 @ $36.82 0 Comment
TrackWedbush 87.61 3/18/2009 Outperform NS $28.75 +49.77% +45.51% +4.27 1/5/2010 @ $43.06 0 Comment
trackthinkequity 86.69 3/4/2009 Outperform NS $29.14 +469.32% +292.51% +176.81 0 Comment
trackthinkequity 86.69 1/27/2009 Underperform NS $31.56 -7.67% -15.32% -7.65 3/4/2009 @ $29.14 0 Comment
TrackCreditSuiss 90.98 11/25/2008 Outperform NS $22.24 +98.61% +61.53% +37.07 11/12/2012 @ $44.17 0 Comment
trackmerriman 69.74 10/30/2008 Outperform NS $22.73 +76.20% +15.67% +60.53 11/17/2009 @ $40.05 0 Comment
TrackNeedham 91.28 9/26/2008 Outperform NS $32.94 +44.60% +11.83% +32.76 3/31/2011 @ $47.63 0 Comment
TrackJMP 83.26 9/25/2008 Outperform NS $33.20 +6.72% -8.12% +14.84 9/8/2010 @ $35.43 0 Comment
TrackCowenandCo 84.67 6/5/2008 Outperform NS $31.29 +430.20% +105.31% +324.89 0 Comment
TrackPacificGrow < 20 5/21/2008 Outperform NS $25.79 +38.81% -1.15% +39.96 4/17/2012 @ $35.80 0 Comment
TrackLeerinkSwan 95.73 4/25/2008 Outperform NS $24.85 +567.61% +104.29% +463.31 0 Comment
TrackZacks < 20 4/3/2008 Outperform 3M $25.40 +26.93% -0.55% +27.48 6/7/2008 @ $32.24 1 Comment
TrackRWBaird 88.68 4/1/2008 Outperform NS $23.40 +39.66% -5.14% +44.80 11/8/2011 @ $32.68 0 Comment
TrackSusquehanna 92.06 3/31/2008 Outperform NS $23.58 +603.56% +114.94% +488.63 0 Comment
TrackJMP 83.26 1/29/2008 Outperform NS $20.50 +34.88% +1.45% +33.43 6/4/2008 @ $27.65 0 Comment
TrackBofASec 94.15 1/16/2008 Outperform NS $24.08 +588.95% +108.42% +480.53 0 Comment
TrackWellsFargo 86.41 1/3/2008 Underperform NS $21.86 +7.04% -7.64% -14.68 4/1/2008 @ $23.40 0 Comment
TrackLazardCapit 83.30 12/13/2007 Underperform NS $24.25 -36.08% -10.44% +25.65 3/12/2008 @ $15.50 0 Comment
TrackEdwardOwens 99.18 9/30/2007 Outperform NS $38.41 +331.92% +88.64% +243.28 6 Comments
TrackBMOCapital < 20 9/28/2007 Outperform NS $37.24 +345.49% +88.85% +256.64 0 Comment
TrackCowenandCo 84.67 8/8/2007 Outperform NS $37.99 -18.98% +2.94% -21.92 10/19/2007 @ $30.78 0 Comment
TrackStifel 92.10 6/26/2007 Outperform NS $26.35 +529.60% +92.71% +436.89 0 Comment
TrackMaximGroup 59.14 4/16/2007 Underperform NS $28.79 +476.16% +98.64% -377.52 0 Comment
TrackBofASec 94.15 12/14/2006 Underperform NS $37.81 -20.87% -0.96% +19.91 3/12/2007 @ $29.92 0 Comment
TrackRodmanRen < 20 12/1/2006 Outperform NS $44.01 -40.99% +6.64% -47.63 11/5/2007 @ $25.97 0 Comment
TrackSusquehanna 92.06 11/21/2006 Underperform NS $44.90 -15.10% +1.72% +16.82 1/17/2007 @ $38.12 0 Comment
TrackPiperJaff 85.56 11/20/2006 Outperform NS $44.31 +9.75% -1.29% +11.04 8/1/2012 @ $48.63 0 Comment
TrackMaximGroup 59.14 9/7/2006 Outperform NS $34.85 +11.59% +9.92% +1.67 12/15/2006 @ $38.89 0 Comment
TrackUBS 92.31 8/25/2006 Outperform NS $33.34 +397.60% +126.01% +271.59 0 Comment
TrackJimCramer 85.60 7/10/2006 Outperform 3W $35.22 -23.20% -34.24% +11.04 4/6/2009 @ $27.05 0 Comment

Featured Broker Partners